Vivimed Labs Stock Price - ₹6.58 | Healthcare

Exchange filings, newest first

Results, presentation and transcript tracked for every quarter

Quarterly Result Q3 FY2025-26

8 pages

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

17 pages

Annual Reports 2024-25

185 pages

KMP changes, governance and LODR disclosures

DateFilingCategory

26 Sept 2026Vivimed Labs Ltd CoC approves application to RoC for 3-month extension of time to convene AGM for FY26Insolvency

8 Sept 2026Vivimed Labs Ltd intimation of upcoming 7th meeting of Committee of Creditors scheduled on 10 Sep 2026Insolvency

19 May 2026Vivimed Labs Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on 19.05.2026Audit Reports